Gilead questions WHO study that found remdesivir has little effect on Covid-19 deaths

• The UN health agency said its ‘Solidarity’ trial conducted in 11,266 patients had concluded that remdesivir did little to help patients survive
• The US company said the the findings were premature and that other studies had validated the drug’s benefits